Patents by Inventor Scott Uhland

Scott Uhland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230210781
    Abstract: A drug delivery device includes an enteric capsule enclosing an internal volume and a plurality of drug containing particles positioned within the internal volume. Each of the plurality of drug containing particles includes a matrix body and an active pharmaceutical ingredient (API) distributed within the matrix body. The plurality of drug containing particles are configured to penetrate tissue, such as intestinal mucosa.
    Type: Application
    Filed: June 10, 2021
    Publication date: July 6, 2023
    Inventors: Scott UHLAND, Mihee KIM, Manish MONGA, Samuel SPIGELMAN
  • Publication number: 20230007883
    Abstract: Various exemplary methods, systems, and devices for injection pump needle mechanics are provided.
    Type: Application
    Filed: November 16, 2020
    Publication date: January 12, 2023
    Inventors: Steven M. VESOLE, Brandon MCKENZIE, Scott UHLAND
  • Patent number: 11547447
    Abstract: Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: January 10, 2023
    Assignee: Palo Alto Research Center Incorporated
    Inventors: David Mathew Johnson, Scott A. Uhland, Robert Thomas Krivacic, Ramkumar Abhishek, Martin Sheridan
  • Publication number: 20210169525
    Abstract: Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
    Type: Application
    Filed: February 22, 2021
    Publication date: June 10, 2021
    Inventors: David Mathew Johnson, Scott A. Uhland, Ramukumar Abhishek, Robert Thomas Krivacic, Martin Sheridan
  • Patent number: 10925644
    Abstract: Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: February 23, 2021
    Assignee: Palo Alto Research Center Incorporated
    Inventors: David Mathew Johnson, Scott A. Uhland, Ramkumar Abhishek, Robert Thomas Krivacic, Martin Sheridan
  • Patent number: 10806629
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: October 20, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Patent number: 10806630
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: October 20, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Publication number: 20200297531
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Application
    Filed: April 29, 2020
    Publication date: September 24, 2020
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Patent number: 10632294
    Abstract: Devices and methods are provided for transmucosal drug delivery. The transmucosal drug delivery device may include a housing configured for intralumenal deployment, such as intravaginally, into a human or animal subject; a drug-dispensing portion which contains at least one drug, the drug-dispensing portion being configured to dispense the drug from the housing by positive displacement; and a permeability enhancer-dispensing portion configured to release or generate a permeability enhancing substance to disrupt at least one region of a mucosal barrier adjacent to the housing at a selected time while intralumenally deployed in the human or animal subject. The device may be operable to dispense the drug from the housing to a region of the mucosal barrier disrupted by the permeability enhancing substance.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: April 28, 2020
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Scott Uhland, Eric Peeters, Hussain Fatakdawala
  • Patent number: 10596358
    Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: March 24, 2020
    Assignee: PALO ALTO RESEARCH CENTER INCORPORATED
    Inventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
  • Patent number: 10278675
    Abstract: Devices, systems, and methods for detecting estrus in subjects are provided. Devices include a housing configured for intravaginal/intrauterine deployment and retention and a sensor disposed in or on the housing, and are configured to use condition information sensed by the sensor to determine an estrus condition of the subject. Methods include deploying a device in the subject, sensing the condition information, and determining an estrus condition using the condition information. Systems include a device configured to communicate with a base station and/or with other implanted devices, which are located within a reception radius thereof, regarding the determined estrus condition.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: May 7, 2019
    Assignee: PALO ALTO RESEARCH CENTER INCORPORATED
    Inventors: David Mathew Johnson, Scott A. Uhland, Ramkumar Abhishek, Robert Thomas Krivacic, Martin Sheridan
  • Publication number: 20180338904
    Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and a reservoir contained within the housing and having an actuation end and a release end. The release end may include at least one outlet. A first drug formulation and a second drug formulation may be disposed within the reservoir and adjacent to each other and immiscible, or separated from each other by a first barrier. The device may also include a plug within the reservoir at the actuation end, the plug being movable toward the release end to drive the first and second drug formulations out of the reservoir. The device may also include an actuation system operably connected to the actuation end of the reservoir and configured to drive the plug toward the release end and release the drug formulations from the reservoir.
    Type: Application
    Filed: June 1, 2018
    Publication date: November 29, 2018
    Applicant: Inguran, LLC
    Inventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley
  • Patent number: 10064995
    Abstract: Approaches for determining the delivery success of a particle, such as a drug particle, are disclosed. A system for monitoring delivery of particles to biological tissue includes a volume, an optical component, a detector, and an analyzer. The volume comprises a space through which a particle can pass in a desired direction. The optical component is configured to provide a measurement light. The detector is positioned to detect light emanating from the particle in response to the measurement light. The detected light is modulated as the particle moves along a detection axis. The detector is configured to generate a time-varying signal in response to the detected light. The analyzer is configured to receive the time-varying signal and determine a delivery success of the particle into a biological tissue based upon characteristics of the time-varying signal.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: September 4, 2018
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Peter Kiesel, Joerg Martini, Eugene M. Chow, Scott Uhland, Noble M. Johnson
  • Patent number: 9999720
    Abstract: Devices and methods are provided for drug delivery. The device may include a housing having a first compartment containing a drug in a dry, solid form, a second compartment containing a liquid carrier for the drug, and an expansion member located within or adjacent to the first or second compartment. The second compartment may be fluidly connectable to the first compartment by a rupturable barrier or mechanical valve. The device may also include an actuation system configured to expand the expansion member to rupture the rupturable barrier or open the mechanical valve and permit the liquid carrier to flow into the first compartment and mix with the drug to form a reconstituted drug solution.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: June 19, 2018
    Assignee: PALO ALTO RESEARCH CENTER INCORPORATED
    Inventors: Scott A. Uhland, Felicia Linn, Michael I. Recht
  • Publication number: 20180028228
    Abstract: Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
    Type: Application
    Filed: October 9, 2017
    Publication date: February 1, 2018
    Inventors: David Mathew Johnson, Scott A. Uhland, Ramkumar Abhishek, Robert Thomas Krivacic, Martin Sheridan
  • Publication number: 20170360606
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Application
    Filed: May 31, 2017
    Publication date: December 21, 2017
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Publication number: 20170319834
    Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.
    Type: Application
    Filed: July 24, 2017
    Publication date: November 9, 2017
    Inventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
  • Patent number: 9801660
    Abstract: Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: October 31, 2017
    Assignee: Palo Alto Research Center Incorporated
    Inventors: David Mathew Johnson, Scott A. Uhland, Ramkumar Abhishek, Robert Thomas Krivacic, Martin Sheridan
  • Patent number: 9744341
    Abstract: Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: August 29, 2017
    Assignee: Palo Alto Research Center Incorporated
    Inventors: David Mathew Johnson, Martin Sheridan, Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn, Philipp H. Schmaelzle
  • Patent number: 9717526
    Abstract: Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: August 1, 2017
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Scott A. Uhland, Ramkumar Abhishek, Eric Peeters, Timothy J. Curley, Felicia Linn